Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single-lineage marrow failure: a pilot study and a survey from the EBMT WPSAA

✍ Scribed by Antonio Maria Risitano; Carmine Selleri; Bianca Serio; Giovanni Fernando Torelli; Alexander Kulagin; Sébastien Maury; Jörg Halter; Vikas Gupta; Andrea Bacigalupo; Gerard Sociè; André Tichelli; Hubert Schrezenmeier; Judith Marsh; Jakob Passweg; Bruno Rotoli; on behalf of the Working Party Severe Aplastic Anaemia (WPSAA) of the European Group for Blood; Marrow Transplantation (EBMT)

• Book ID: 108676625
• Publisher: John Wiley and Sons
• Year: 2010
• Tongue: English
• Weight: 120 KB
• Volume: 148
• Category: Article
• ISSN: 0007-1048
• DOI: 10.1111/j.1365-2141.2009.08027.x